NIH logo.png
X4 Pharma.jpg


We just got our RO1 renewed (June 10, 2019), and we were awarded a new R21. It’s about time to grow the lab. Interested in joining the lab? The timing is perfect now!

Our lab research captured the attention of X4 Pharmaceuticals. We are currently working towards understanding and providing therapeutic solutions for patients with a rare immunodeficiency disorder called WHIM syndrome.




Our study on lymphopoietic niches previewed in Immunity.

Our study on cell circuit control of B cell development has a very nice News and Views from Susan Schwab (a former “baymate” in the Cyster lab.)


Studies on B cell egress displayed on the cover of the Journal of Experimental Medicine and highlighted on their Facebook page